These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33229626)

  • 21. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
    Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP
    Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of SRD5A3 and its prognostic significance in breast cancer.
    Zhang YP; Na WT; Dai XQ; Li RF; Wang JX; Gao T; Zhang WB; Xiang C
    World J Surg Oncol; 2021 Aug; 19(1):260. PubMed ID: 34465365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.
    Wang X; Wang Y; Zhang Q; Zhuang H; Chen B
    Med Sci Monit; 2018 Mar; 24():1759-1767. PubMed ID: 29576605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
    Zhao F; Gong X; Liu A; Lv X; Hu B; Zhang H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1136-1143. PubMed ID: 29175326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation.
    Ding Y; Liu X; Yuan Y; Sheng Y; Li D; Ojha SC; Sun C; Deng C
    Aging (Albany NY); 2022 Feb; 14(4):1743-1766. PubMed ID: 35196258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
    Ruan J; Zheng H; Rong X; Rong X; Zhang J; Fang W; Zhao P; Luo R
    Mol Cancer; 2016 Feb; 15():17. PubMed ID: 26896959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.
    Zhang Z; Huang S; Wang H; Wu J; Chen D; Peng B; Zhou Q
    Biochem Biophys Res Commun; 2016 Jun; 474(4):673-679. PubMed ID: 27155152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Zhao R; Li L; Yang J; Niu Q; Wang H; Qin X; Zhu N; Shi A
    Pathol Oncol Res; 2020 Apr; 26(2):853-860. PubMed ID: 30852741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5.
    Fu B; Meng W; Zhao H; Zhang B; Tang H; Zou Y; Yao J; Li H; Zhang T
    Sci Rep; 2016 Sep; 6():31963. PubMed ID: 27585821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.
    Jin Y; Li Q; Qiu J; Zhao X; Zheng C; Lv S; Bai Y; Shan Y; Ye LC
    Tumour Biol; 2016 Oct; 37(10):14193-14203. PubMed ID: 27553024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.